IMA vs SPG · rev $9.2M vs rev $1.79B
ImageneBio, Inc. (IMA) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
SPG (SPG) common stock.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported SPG revenue for 2025-12-31 was $1.79B. Net income was $3.54B. Revenue was up 13.2% from 2024-12-31 to 2025-12-31. SPG currently screens at market cap $0.
IMA currently screens at market cap $64.7M. SPG currently screens at market cap $0.
Not investment advice. Open the IMA and SPG stock pages for the full models.
Not investment advice.